Skip to main content
Log in

Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma

  • Original Papers
  • Clinical Oncology or Epidemiology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Summary

A 55-year-old white woman received chemotherapy with DTIC after surgery for malignant melanoma (stage I, SSM IV, depth of invasion 12 mm). She died suddenly during the second treatment cycle. Autopsy revealed massive necrosis of the liver and thrombosis of the hepatic veins. The cause of the fatal outcome is attributed to the adverse toxic effects of DTIC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Baird, G.M., Willoughby, M.L.N.: Photodegradation of dacarbazine. Lancet 1978/23, 681

    Google Scholar 

  • Costanza, M.E., Nathanson, L., Schoenfeld, D., Wolter, J., Colsky, J., Regelson, W, Cunningham, T., Sedransk, N.: Results with methyl-CCNU and DTIC in metastatic melanoma. Cancer 40, 1010–1015 (1977)

    Google Scholar 

  • Griner, P.F., Elbadawi, A., Packman, C.H.: Veno-occlusive disease of the liver after chemotherapy of acute leukemia. Report of two cases. Ann. Intern. Med. 85, 578–582 (1976)

    Google Scholar 

  • Johnson, R.O., Metter, G., Wilson, W., Hill, G., Krementz, E.: Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the central oncology group. Cancer Treatm. Rep. 60, 183–187 (1976)

    Google Scholar 

  • Lehrner, L.M., Enck, R.E.: Hepatic vein thrombosis after chemotherapy for histiocytoma. Ann. Intern. Med. 88, 575–576 (1978)

    Google Scholar 

  • Loo, T.L., Housholder, G.E., Gerulath, A.H., Saunders, P.H., Farquhar, D.: Mechanism of action and pharmacology studies with DTIC (NSC-45388) Cancer Treatm. Rep. 60, 149–152 (1976)

    Google Scholar 

  • Luce, J.K.: Chemotherapy of malignant melanoma. Cancer 30, 1604–1615 (1972)

    Google Scholar 

  • Saunder, P.P., Schultz, G.A.: Studies of the mechanism of action of the antitumor agent [5(4)-(3,3-dimethyl-1-triazeno]imidazole-4(5)-carcoxamide in Bacillus subtilis. Biochem. Pharmacol. 19, 911 (1970)

    Google Scholar 

  • Skibba, J.L., Beal, D.D., Ramirez, G., Bryan, G.T.: N-demethylation of the antineoplastic agent 4(5)-(3.3-dimethyl-1-triazeno) imidazole-5(4)carbox-amide by rats and man. Cancer Res. 30, 147 (1970)

    Google Scholar 

  • Wagner, D.E., Ramirez, G., Weiss, A.J., Hill, G., Jr.: Combination phase 1-II study of imidazole carboxamide (NCS-45388). Oncology 26, 310–316 (1971)

    Google Scholar 

  • Wasser, J.S., Coleman, M.: Leukemia chemotherapy and centrilobular hepatic necrosis. Ann. Intern. Med. 86, 508–509 (1977)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frosch, P.J., Czarnetzki, B.M., Macher, E. et al. Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma. J Cancer Res Clin Oncol 95, 281–286 (1979). https://doi.org/10.1007/BF00410649

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00410649

Key words

Navigation